ArticleRheumatology international2026
Temporomandibular disorders in women with psoriatic arthritis by history of psoriasis: a cross-sectional study.
Article in Rheumatology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Temporomandibular joint involvement in psoriatic arthritis may result in impaired jaw function and reduced oral health-related quality of life. Patients with PsA have generally been analyzed as a single group regardless of psoriasis history, despite a reported association between psoriasis and TMJ involvement. To assess TMD symptoms, patient-reported outcome measures, and self-reported beneficial effects of systemic therapies and TMD-related treatment modalities in women with psoriatic arthritis, stratified by psoriasis history. A digital questionnaire was sent to members aged ≥ 18 years of the Swedish Rheumatism Association from March through September 2022. The study included 27 women with self-reported PsA diagnosed within the healthcare system. Descriptive analyses were performed to describe socio-demographic, disease-related, TMD-related, and patient-reported outcome measures stratified by psoriasis history. Pain during jaw activity (77.8%), TMJ sounds (74.1%), and morning jaw stiffness/pain/fatigue (66.6%) were the most reported symptoms in the total sample. The proportions were higher among women with a history of psoriasis compared with those without a history of psoriasis (81.8% vs. 75.0%, 81.8% vs. 68.8%, and 72.7% vs. 62.5%, respectively). Those with psoriasis history had higher median (Q1-Q3) JFLS-8 scores [18 (5-22) vs. 11.5 (8-17.5)] and higher mean (SD) OHIP-14 scores (16.7 ± 7.7 vs. 9.6 ± 7.4) than those without psoriasis history. A perceived beneficial effect of systemic PsA medication on TMD symptoms was reported by 40% and 30%, respectively. Occlusal adjustment in the psoriasis-history group and bite splint therapy in the other group were reported as the most received and most beneficial treatments in the respective. Women with PsA reported TMD symptoms and impaired patient-reported outcomes, with higher proportions reported in the psoriasis-history group. Self-reported beneficial effects of systemic and TMD-related treatments varied between groups. Findings should be interpreted cautiously given the small sample size and descriptive design. Further studies with larger samples are recommended.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.